These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

290 related articles for article (PubMed ID: 20484881)

  • 1. Ethanol sclerotherapy of superficial venous malformation: a new procedure.
    Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
    Dermatology; 2010; 220(4):376-80. PubMed ID: 20484881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ethanol sclerotherapy of peripheral venous malformations.
    Rimon U; Garniek A; Galili Y; Golan G; Bensaid P; Morag B
    Eur J Radiol; 2004 Dec; 52(3):283-7. PubMed ID: 15544907
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outpatient percutaneous treatment of deep venous malformations using pure ethanol at low doses under local anesthesia.
    Orlando JL; Caldas JG; Campos HG; Nishinari K; Wolosker N
    Clinics (Sao Paulo); 2010; 65(9):837-40. PubMed ID: 21049209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sclerotherapy of peripheral venous malformations: a new technique to prevent serious complications.
    Ierardi AM; Mangini M; Vaghi M; Cazzulani A; Carrafiello G; Mattassi R
    Vasc Endovascular Surg; 2010 May; 44(4):282-8. PubMed ID: 20403950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Percutaneous treatment of facial venous malformations: a matched comparison of alcohol and bleomycin sclerotherapy.
    Spence J; Krings T; TerBrugge KG; Agid R
    Head Neck; 2011 Jan; 33(1):125-30. PubMed ID: 20848431
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sclerotherapy for vascular malformations: complications and a review of techniques to avoid them.
    Odeyinde SO; Kangesu L; Badran M
    J Plast Reconstr Aesthet Surg; 2013 Feb; 66(2):215-23. PubMed ID: 23059134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective analysis of facial paralysis caused by ethanol sclerotherapy for facial venous malformation.
    Hu X; Chen D; Jiang C; Jin Y; Chen H; Ma G; Lin X
    Head Neck; 2011 Nov; 33(11):1616-21. PubMed ID: 21990226
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictors of response to percutaneous ethanol sclerotherapy (PES) in patients with venous malformations: analysis of patient self-assessment and imaging.
    Yun WS; Kim YW; Lee KB; Kim DI; Park KB; Kim KH; Do YS; Lee BB
    J Vasc Surg; 2009 Sep; 50(3):581-9, 589.e1. PubMed ID: 19540703
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ethanol sclerotherapy of head and neck venous malformations.
    Orlando JL; Caldas JG; Campos HG; Nishinari K; Krutman M; Wolosker N
    Einstein (Sao Paulo); 2014 Apr; 12(2):181-6. PubMed ID: 25003923
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New experiences with absolute ethanol sclerotherapy in the management of a complex form of congenital venous malformation.
    Lee BB; Kim DI; Huh S; Kim HH; Choo IW; Byun HS; Do YS
    J Vasc Surg; 2001 Apr; 33(4):764-72. PubMed ID: 11296330
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MR imaging-guided percutaneous sclerotherapy of peripheral venous malformations with a clinical 1.5-T unit: a pilot study.
    Andreisek G; Nanz D; Weishaupt D; Pfammatter T
    J Vasc Interv Radiol; 2009 Jul; 20(7):879-87. PubMed ID: 19481473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advanced management of venous malformation with ethanol sclerotherapy: mid-term results.
    Lee BB; Do YS; Byun HS; Choo IW; Kim DI; Huh SH
    J Vasc Surg; 2003 Mar; 37(3):533-8. PubMed ID: 12618688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-saving isolation procedure in percutaneous ethanol sclerotherapy for venous malformations.
    Kishi K; Morita N; Terada T; Sato M
    Phlebology; 2014 Jun; 29(5):276-86. PubMed ID: 23508004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sclerotherapy after embolization of draining vein: a safe treatment method for venous malformations.
    Jin Y; Lin X; Li W; Hu X; Ma G; Wang W
    J Vasc Surg; 2008 Jun; 47(6):1292-9. PubMed ID: 18387776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ethanol sclerotherapy for the management of craniofacial venous malformations: the interim results.
    Lee IH; Kim KH; Jeon P; Byun HS; Kim HJ; Kim ST; Kim YW; Kim DI; Choi JY
    Korean J Radiol; 2009; 10(3):269-76. PubMed ID: 19412515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digital subtraction angiography-guided percutaneous sclerotherapy of venous malformations with pingyangmycin and/or absolute ethanol in the maxillofacial region.
    Li J; Chen J; Zheng G; Liao G; Fu Z; Li J; Zhang T; Su Y
    J Oral Maxillofac Surg; 2010 Sep; 68(9):2258-66. PubMed ID: 20381941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Utility of intralesional sclerotherapy with 3% sodium tetradecyl sulphate in cutaneous vascular malformations.
    Khandpur S; Sharma VK
    Dermatol Surg; 2010 Mar; 36(3):340-6. PubMed ID: 20100267
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct percutaneous ethanol instillation for treatment of venous malformation in the face and neck.
    Lee CH; Chen SG
    Br J Plast Surg; 2005 Dec; 58(8):1073-8. PubMed ID: 16055097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Absolute ethanol sclerotherapy for venous malformations in the face and neck.
    Su L; Fan X; Zheng L; Zheng J
    J Oral Maxillofac Surg; 2010 Jul; 68(7):1622-7. PubMed ID: 19962811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol-Gel Sclerotherapy of Venous Malformations: Effectiveness and Safety.
    Teusch VI; Wohlgemuth WA; Hammer S; Piehler AP; Müller-Wille R; Goessmann H; Uller W
    AJR Am J Roentgenol; 2017 Dec; 209(6):1390-1395. PubMed ID: 28929808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.